Inpharma Weekly

, Volume 1292, Issue 1, pp 6–6 | Cite as

α-Galactosidase appears to decrease cardiac mass and correct the metabolic defect of Fabry's disease,

Media release
  • 4 Downloads

Keywords

Placebo Clinical Result Placebo Recipient Medium Release Ventricular Hypertrophy 

Copyright information

© Adis International Ltd 2001

Personalised recommendations